AQST
Aquestive Therapeutics, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$3.94-4.25%
Price as of Jul 20, 2026
AQST valuation
Aquestive Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.79x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -14.53x
- Price / sales
- 9.84x
- Price / cash flow
- -11.29x
Enterprise value
- Enterprise value
- $517.7M
- EV / sales
- 10.30x
- EV / EBITDA
- -10.03x
- EV / EBIT
- -9.26x
- Market cap
- $494.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.